Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma

by Sobhani, Navid, Corona, Silvia P., Zanconati, Fabrizio, Generali, Daniele
Published in Genes Cancer (2017)

Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study

by Corona, Silvia P., Giudici, Fabiola, Jerusalem, Guy, Ciruelos, Eva, Strina, Carla, Sirico, Marianna, Bernocchi, Ottavia, Milani, Manuela, Dester, Martina, Ziglioli, Nicoletta, Barbieri, Giuseppina, Cervoni, Valeria, Montemurro, Filippo, Generali, Daniele
Published in Oncotarget (2020)

Early Changes of the Standardized Uptake Values (SUV(max)) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer

by Sirico, Marianna, Bernocchi, Ottavia, Sobhani, Navid, Giudici, Fabiola, Corona, Silvia P., Vernieri, Claudio, Nichetti, Federico, Cappelletti, Maria Rosa, Milani, Manuela, Strina, Carla, Cervoni, Valeria, Barbieri, Giuseppina, Ziglioli, Nicoletta, Dester, Martina, Bianchi, Giulia Valeria, De Braud, Filippo, Generali, Daniele
Published in Cancers (Basel) (2020)